167 related articles for article (PubMed ID: 23494102)
1. Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment.
Halachmi S; Gabari O; Cohen S; Koren R; Amitai DB; Lapidoth M
Lasers Med Sci; 2014 Jan; 29(1):137-40. PubMed ID: 23494102
[TBL] [Abstract][Full Text] [Related]
2. Case series of pulsed dye laser treatment of telangiectasia in 23 patients with systemic sclerosis.
Burillo-Martinez S; Prieto-Barrios M; Velasco-Tamariz V; Tous-Romero F; López-Gómez S; Maroñas-Jimenez L
Int J Dermatol; 2017 Aug; 56(8):e165-e167. PubMed ID: 28317090
[No Abstract] [Full Text] [Related]
3. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
Lie JT
Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome.
Duchini A; Sessoms SL
Am J Gastroenterol; 1998 Sep; 93(9):1453-6. PubMed ID: 9732924
[TBL] [Abstract][Full Text] [Related]
5. Using the ultra-long pulse width pulsed dye laser and elliptical spot to treat resistant nasal telangiectasia.
Madan V; Ferguson J
Lasers Med Sci; 2010 Jan; 25(1):151-4. PubMed ID: 19636662
[TBL] [Abstract][Full Text] [Related]
6. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis for facial telangiectasia treatment using pulsed dye laser and intense pulsed light configured with different wavelength bands.
Gao L; Qu H; Gao N; Li K; Dang E; Tan W; Wang G
J Cosmet Dermatol; 2020 Jan; 19(1):88-92. PubMed ID: 31638320
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser.
Halachmi S; Israeli H; Ben-Amitai D; Lapidoth M
Lasers Med Sci; 2014 Jan; 29(1):321-4. PubMed ID: 23681198
[TBL] [Abstract][Full Text] [Related]
9. The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).
Velayos EE; Masi AT; Stevens MB; Shulman LE
Arch Intern Med; 1979 Nov; 139(11):1240-4. PubMed ID: 508020
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
Salerni R; Rodnan GP; Leon DF; Shaver JA
Ann Intern Med; 1977 Apr; 86(4):394-9. PubMed ID: 848800
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia.
Kwon WJ; Park BW; Cho EB; Park EJ; Kim KH; Kim KJ
J Cosmet Laser Ther; 2018 Oct; 20(5):260-264. PubMed ID: 29388843
[TBL] [Abstract][Full Text] [Related]
12. The CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia).
Brown AE
Br J Oral Surg; 1976 Nov; 14(2):137-42. PubMed ID: 1070339
[TBL] [Abstract][Full Text] [Related]
13. Prominent telangiectasia associated with marked bleeding in CREST syndrome.
Ueda M; Abe Y; Fujiwara H; Fujimoto W; Arakawa K; Arata J; Yoshioka T; Tomoda J; Katayama H
J Dermatol; 1993 Mar; 20(3):180-4. PubMed ID: 8478499
[TBL] [Abstract][Full Text] [Related]
14. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece.
Tanghetti EA
Lasers Surg Med; 2012 Feb; 44(2):97-102. PubMed ID: 22180317
[TBL] [Abstract][Full Text] [Related]
15. Fractional 532-nm KTP diode laser and 595-nm pulsed dye laser in treatment of facial telangiectatic erythema.
Nam CH; Kim MH; Hong SP; Park BC
J Cosmet Dermatol; 2019 Jun; 18(3):783-787. PubMed ID: 29974643
[TBL] [Abstract][Full Text] [Related]
16. Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study.
Trostle DC; Bedetti CD; Steen VD; Al-Sabbagh MR; Zee B; Medsger TA
Arthritis Rheum; 1988 Mar; 31(3):393-400. PubMed ID: 3358801
[TBL] [Abstract][Full Text] [Related]
17. [Vascular manifestations in systemic sclerosis (scleroderma)].
Cafagna D; Melon F; Balbi M; Ponte E
Minerva Med; 1998 May; 89(5):153-61. PubMed ID: 9676180
[TBL] [Abstract][Full Text] [Related]
18. Parafoveal telangiectasia in association with CREST syndrome.
Proctor B; Chang T; Hay D
Arch Ophthalmol; 1998 Jun; 116(6):814-5. PubMed ID: 9639458
[No Abstract] [Full Text] [Related]
19. [Pulmonary hypertension in diffuse scleroderma and the CREST syndrome].
Presetnik M; Music E; Kolsek B; Rozman B
Plucne Bolesti; 1989; 41(1-2):5-7. PubMed ID: 2798573
[TBL] [Abstract][Full Text] [Related]
20. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
Fritzler MJ; Kinsella TD
Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
